Biomet Hip Implant surgeries are used to remove the arthritic ball of the upper thighbone as well as any damaged bone or cartilage from the hip socket, and the new Biomet implant was designed to create a new and smooth functioning joint that relieves and replaces the pain of the original bone on bone contact.
However, Biomet Incorporated, a United States Pharmaceutical Company established in 1977, has been the focus of thousands of lawsuits throughout the United States due to product defects linked to metallosis, or metal poisoning, as well as other serious side effects.
Side effects of Biomet Hip Implant Systems include,
- Vertigo (inappropriately experiencing the perception of motion)
- Peripheral neuropathy (damage to the peripheral nerves causing weakness, numbness and pain)
- Hypothyroidism (underactive thyroid)
- Metallosis (metal poisoning)
- Optic nerve damage (inflammation of the optic nerve)
- Convulsions (uncontrolled shaking of the body)
- Tinnitus (noise or ringing in the ear)
In January 2014, Biomet Incorporated agreed to a $56MM settlement in multi-district court on the metal-on-metal replacement for the M2a 38 and Magnum model. The average settlement is estimated around $200K per case depending on the month and year of the implant. Trials will begin in 2015.